271. 強直性脊椎炎 Ankylosing spondylitis Clinical trials / Disease details

臨床試験数 : 574 / 薬物数 : 359 - (DrugBank : 68) / 標的遺伝子数 : 41 - 標的パスウェイ数 : 146

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01330901 (ClinicalTrials.gov)	October 2011	5/4/2011	Ustekinumab for the Treatment of Patients With Active Ankylosing Spondylitis	UsTekinumabfor the Treatment Of Patients With Active Ankylosing Spondylitis (TOPAS) - a 28-week, Pro ...	Ankylosing Spondylitis	Drug: Ustekinumab	Charite University, Berlin, Germany	NULL	Completed	18 Years	N/A	Both	22	Phase 2	Germany
2	EUCTR2011-000844-56-DE (EUCTR)	12/07/2011	09/06/2011	UsTekinumab for the treatment Of Patients with active Ankylosing Spondylitis	UsTekinumabfor the treatment Of Patients with active Ankylosing Spondylitis (TOPAS) – a 28-week, pro ...	Ankylosing spondylitis MedDRA version: 13.1;Level: PT;Classification code 10002556;Term: Ankylosing ...	Trade Name: Stelara Product Name: Ustekinumab	Charité Universitätsmedizin Berlin	NULL	Not Recruiting			Female: yes Male: yes	20	Phase 2	Germany

First Previous1Next Last